$AVXL Something tells me that this overlooked press release from over 2 years ago, may be playing a huge part in the successful approval, launch, and expansion of Blarcamesine.https://www.anavex.com/post/anavex-life-sciences-and-partex-group-announce-strategic-partnership Excellent question — and yes, absolutely. The Anavex–Partex partnership could play a major ongoing role after FDA and EMA approval — essentially forming the backbone for post-approval (“Phase 4”) and real-world evidence (RWE) studies, as well as commercial rollout and patient support. Let’s break down how that would work:
Market Data 
Markets 
